Skip to main content
. Author manuscript; available in PMC: 2020 May 31.
Published in final edited form as: J Nat Prod. 2017 Aug 24;80(9):2556–2560. doi: 10.1021/acs.jnatprod.7b00452

Table 2.

Biological Activities of Compounds 1–4a

MICs (μg mL−1) anti-HIV IC50’s (μM) cytotoxicity (μM)
compound S. aureus E. coli YU2 HxB2 BSC-1 HCT-116
1 1.2 >100 3.9 2.7 46 10
2 3.7 100 3.5 4.5 93 16
3 1.1 >100 9.5 12 31 27
4 11 >100 57 NAb 120 180
oxacillin 0.25
gentamicin 1
a

See Experimental Section for details of biological assays.

b

NA, not active.